MRK

2026Q2BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-08-04 · Fiscal end 2026-06-30 · Features as of 2026-08-03

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-0.26
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.9%
IV front—
P/C full—
P/C front—
Features as of2026-08-03

Run-up

Close—
Ret 5d-2.3%
Ret 10d+2.7%
Ret 20d+0.8%
Ret 30d+12.2%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-0.13Beat
Estimated EPS-0.26
Actual revenue
16.6B
Surprise %+50.0%
Beat / missBeat
Beat streak 44
Beat streak 87

Reaction

1-day stock reaction-0.4%
Implied vs actual

Implied 1.9%Actual 0.5%

Gap reaction+0.5%
Day result+0.2%
Next-day upNo
Realized / IV0.28×

Post tape

Post 5d+1.9%
Post 10d+5.6%
Post volume11.8M
Vol ×10d1.45×
Vol ×20d1.36×
Post range2.9%